Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 3810-3815

  Roberts, Mark ^a   Bacon, Andrew ^b   Li, Jingli ^b   Chatfield, Steven ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TETANUS TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNE SYSTEM; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA; SEROTYPE;

EID: 0032769214     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.3810-3815.1999     Document Type: Article

References (31)

1. Attridge, S. R., R. Davies, and J. T. LaBrooy. 1997. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 15:155-162.
2. Bao, J. X., and J. D. Clements. 1991. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect. Immun. 59:3841-3845.
3. Cardenas, L., and J. D. Clements. 1992. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:328-342.
4. Cardenas, L., U. Dasgupta, and J. D. Clements. 1994. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 12:833-840.
5. Chabalagoity, J. A., B. Villareal-Ramos, C. M. Khan, S. N. Chatfield, R. D. de Hormaeche, and C. E. Hormaeche. 1995. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier. Infect. Immun. 63:2564-2569.
6. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
7. Chatfield, S. N., N. Fairweather, I. Charles, D. Pickard, M. Levine, D. Hone, M. Posada, R. A. Strugnell, and G. Dougan. 1992. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10:53-60.
8. Clare, J. J., F. B. Rayment, S. P. Ballantine, K. Sreekrishna, and M. A. Romanos. 1991. High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Bio/Technology 9:455-460.
9. Davis, R. W., D. Botstein, and J. R. Roth. 1980. Advanced bacterial genetics: a manual for genetic engineering. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
10. Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic. mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92:1644-1648.
11. Everest, P., G. Frankel, J. Li, P. Lund, S. Chatfield, and G. Dougan. 1995. Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol. Lett. 126:97-101.
12. Fairweather, N. F., S. N. Chatfield, A. J. Makoff, R. A. Strugnell, J. Bester, D. J. Maskell, and G. Dougan. 1990. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1323-1326.
13. Fairweather, N. F., V. A. Lyness, and D. J. Maskell. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
14. Hormaeche, C. E., C. M. Anjam Khan, P. Mastroenii, B. Villareal, M. Roberts, G. Dougan, and S. Chatfield. 1995. Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens, p. 119-154. In D. A. Ala Aldeen and C. E. Hormaeche (ed.), Molecular and clinical aspects of bacterial vaccine development. John Wiley & Sons Ltd., Chichester, England.
15. Hormaeche, C. E., H. S. Joysey, L. Desilva, M. Izhar, and B. A. Stocker. 1991. Immunity conferred by Aro- Salmonella live vaccines. Microb. Pathog. 10:149-158.
16. Hormaeche, C. E., P. Mastroeni, J. A. Harrison, R. Demarco de Hormaeche, S. Svenson, and B. A. Stocker. 1996. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine 14:251-259.
17. Hsu, H. S. 1989. Pathogenesis and immunity in murine salmonellosis. Microbiol. Rev. 53:390-409.
18. Lindberg, A. A., T. Segall, A. Weintraub, and B. A. D. Stocker. 1993. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4.O9 hybrid Salmonella dublin strain. Infect. Immun. 61:1211-1221.
19. Nashar, T. O., H. M. Webb, S. Eaglestone, N. A. Williams, and T. R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin-receptor-binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA 93:226-230.
20. 19a. Roberts, M. Unpublished observation.
21. Roberts, M., A. Bacon, R. Rappuoli, M. Pizza, I. Cropley, G. Douce, G. Dougan, M. Marinaro, J. McGhee, and S. Chatfield. 1995. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/ 129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63:2100-2108.
22. Roberts, M., S. N. Chatfieid, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens, p. 27-58. In D. T. O'Hagan (ed.). Novel delivery systems for oral vaccines. CRC Press, Boca Raton, Fla.
23. Roberts, M., J. Li, A. Bacon, and S. Chatfield. 1998. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect. Immun. 66:3080-3087.
24. Rooney, J. F., C. Wohlenberg, K. J. Cremer, B. Moss, and A. L. Notkins. 1988. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J. Virol. 62:1530-1534.
25. Segall, T., and A. A. Lindberg. 1993. Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing 04,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4,5,12). Infect. Immun. 61:1222-1231.
26. Spangler, B. A. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
27. Stanfield, J. P., and A. Galazka. 1984. Neonatal tetanus in the world today. Bull. W. H. O. 62:647-669.
28. Strugnell, R., G. Dougan, S. Chatfield, I. Charles, N. Fairweather, J. Tite, J. L. Li, J. Beesley, and M. Roberts. 1992. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:3994-4002.
29. Takahashi, I., M. Marinaro, H. Kiyono, R. J. Jackson, I. Nakagawa, K. Fujihashi, S. Hamada, J. D. Clements, K. L. Bost, and J. R. McGhee. 1996. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 173:627-635.
30. Whittle, B. L., and N. K. Verma. 1997. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15:1737-1740.
31. Yei, S., N. Mittereder, K. Tang, C. O'Sullivan, and B. C. Trapnell. 1994. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:192-200.